Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150462
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2005-09-06
Brief Title:
Safety Study of the Proteasome Inhibitor PR-171 Carfilzomib for Injection in Patients With Hematological Malignancies
Sponsor:
Amgen
Organization:
Amgen